Charanjit Aulakh

Array ( [id] => 7685076 [patent_doc_number] => 20100121065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Phosphors with High Luminous Efficiency and Display Device Containing Them' [patent_app_type] => utility [patent_app_number] => 11/814132 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4024 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20100121065.pdf [firstpage_image] =>[orig_patent_app_number] => 11814132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359770 [patent_doc_number] => 07485649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Inhibitors of checkpoint kinases' [patent_app_type] => utility [patent_app_number] => 11/794861 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19036 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485649.pdf [firstpage_image] =>[orig_patent_app_number] => 11794861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904602 [patent_doc_number] => 20080114016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Inhibitors of Checkpoint Kinases' [patent_app_type] => utility [patent_app_number] => 11/794860 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29135 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114016.pdf [firstpage_image] =>[orig_patent_app_number] => 11794860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777416 [patent_doc_number] => 20060106056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Novel quinuclidine derivatives and medicinal compositions containing the same' [patent_app_type] => utility [patent_app_number] => 11/325059 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27463 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106056.pdf [firstpage_image] =>[orig_patent_app_number] => 11325059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777415 [patent_doc_number] => 20060106055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Novel quinuclidine derivatives and medicinal compositions containing the same' [patent_app_type] => utility [patent_app_number] => 11/324919 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27404 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106055.pdf [firstpage_image] =>[orig_patent_app_number] => 11324919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853060 [patent_doc_number] => 07378445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Treatment of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/324587 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 18342 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378445.pdf [firstpage_image] =>[orig_patent_app_number] => 11324587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515711 [patent_doc_number] => 20090216018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'ORGANOMETALLIC COMPLEXES' [patent_app_type] => utility [patent_app_number] => 11/722129 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12402 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216018.pdf [firstpage_image] =>[orig_patent_app_number] => 11722129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777500 [patent_doc_number] => 20060106140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Thermally stable anthrapyridone' [patent_app_type] => utility [patent_app_number] => 11/314866 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5477 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106140.pdf [firstpage_image] =>[orig_patent_app_number] => 11314866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700690 [patent_doc_number] => 20060217375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'New compounds' [patent_app_type] => utility [patent_app_number] => 11/318126 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18187 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217375.pdf [firstpage_image] =>[orig_patent_app_number] => 11318126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649810 [patent_doc_number] => 20060135545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Benzo[b]pyrano[3,2-h]acridin-7-one cinnamate compounds' [patent_app_type] => utility [patent_app_number] => 11/313386 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6548 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135545.pdf [firstpage_image] =>[orig_patent_app_number] => 11313386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 473220 [patent_doc_number] => 07230107 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-12 [patent_title] => 'Metal quinoline complexes' [patent_app_type] => utility [patent_app_number] => 11/303664 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6864 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230107.pdf [firstpage_image] =>[orig_patent_app_number] => 11303664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866137 [patent_doc_number] => 20060100268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Method of treating atherosclerosis or restenosis using microtube stabilizing agent' [patent_app_type] => utility [patent_app_number] => 11/304362 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5767 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100268.pdf [firstpage_image] =>[orig_patent_app_number] => 11304362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 522575 [patent_doc_number] => 07186727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Pyridyl-substituted spiro-hydantoin compounds and use thereof' [patent_app_type] => utility [patent_app_number] => 11/301454 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23209 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186727.pdf [firstpage_image] =>[orig_patent_app_number] => 11301454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656583 [patent_doc_number] => 20060142319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Pyridyl-substituted spiro-hydantoin crystalline forms and process' [patent_app_type] => utility [patent_app_number] => 11/301433 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23914 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142319.pdf [firstpage_image] =>[orig_patent_app_number] => 11301433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 300020 [patent_doc_number] => 07538222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'N-substituted piperidine derivatives as serotonin receptor agents' [patent_app_type] => utility [patent_app_number] => 11/299566 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39448 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538222.pdf [firstpage_image] =>[orig_patent_app_number] => 11299566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859056 [patent_doc_number] => 20080267906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity' [patent_app_type] => utility [patent_app_number] => 11/792581 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30350 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267906.pdf [firstpage_image] =>[orig_patent_app_number] => 11792581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441873 [patent_doc_number] => 20090093512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => '1, 2, 3, 3A, 8, 8A-HEXAHYDRO-2, 7A-DIADA-CYCLOPENTA[A]INDEN-7-ONE DERIVATIVES WHICH BIND TO NEURONAL NICOTINIC ACETYLCHOLINE SPECIFIC RECEPTOR SITES AND ARE USEFUL IN MODULATING CHOLINERGIC FUNCTION AND IN THE TREATMENT OF ADDICTIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/814168 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8900 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093512.pdf [firstpage_image] =>[orig_patent_app_number] => 11814168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609137 [patent_doc_number] => 20060270653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 11/288939 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27219 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270653.pdf [firstpage_image] =>[orig_patent_app_number] => 11288939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 424790 [patent_doc_number] => 07270772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Benzopyran colorants, method of manufacture, and method of use' [patent_app_type] => utility [patent_app_number] => 11/289159 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7008 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270772.pdf [firstpage_image] =>[orig_patent_app_number] => 11289159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448811 [patent_doc_number] => 07250424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Fab I inhibitors' [patent_app_type] => utility [patent_app_number] => 11/284660 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38914 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250424.pdf [firstpage_image] =>[orig_patent_app_number] => 11284660 [rel_patent_id] =>[rel_patent_doc_number] =>)